KatariaSRavindranV. Harnessing of real world data and real world evidence using digital tools: utility and potential models in rheumatology practice. Rheumatology(Oxford)2022; 61: 502–13.
2.
RocherLHendrickxJMde MontjoyeYA. Estimating the success of re-identifications in incomplete datasets using generative models. Nat Commun2019; 10: 3069.
3.
NeubauerTHeurixJ. A methodology for the pseudonymization of medical data. Int J Med Inform2011; 80: 190–204.
4.
KayaalpM. Patient privacy in the era of big data. Balkan Med J2018; 35: 8–17.
5.
CasaliPGBielackSAbecassisN, et al. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol2018; 29: iv79–95.
6.
KroesJABansalATBerretE, et al. Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future. ERJ Open Res2022; 8: 00168-2022.
7.
FigueiredoAS. Data sharing: convert challenges into opportunities. Front Public Health2017; 5: 327.
8.
VlahouAHallinanDApweilerR, et al. Data sharing under the general data protection regulation: time to harmonize law and research ethics?Hypertension2021; 77: 1029–35.
9.
GefenasELekstutieneJLukasevicieneV, et al. Controversies between regulations of research ethics and protection of personal data: informed consent at a cross-road. Med Health Care Philos2022; 25: 23–30.
10.
HallinanD. Broad consent under the GDPR: an optimistic perspective on a bright future. Life Sci Soc Policy2020; 16: 1.
